Daphne D Williams

发表

A Phase I Study of Cantuzumab Mertansine Administered as a Single Intravenous Infusion Once Weekly in Patients with Advanced Solid Tumors

R. Schilsky, M. Ratain, M. Russo, 2004, Clinical Cancer Research.

Use of a cocktail probe to assess potential drug interactions with cytochrome P450 after administration of belatacept, a costimulatory immunomodulator

Sean Zhang, Daphne D Williams, E. Masson, 2016, British journal of clinical pharmacology.

Metabolism and Disposition of [14C]Brivanib Alaninate after Oral Administration to Rats, Monkeys, and Humans

V. Arora, A. Allentoff, J. Gan, 2011, Drug Metabolism and Disposition.

Metabolism and Disposition of [ 14 C]Brivanib Alaninate after Oral Administration to Rats, Monkeys, and Humans □ S

V. Arora, A. Allentoff, J. Gan, 2011 .

Effect of Hepatic or Renal Impairment on Eltrombopag Pharmacokinetics

B. Peng, Daphne D Williams, J. Bauman, 2011, Journal of clinical pharmacology.

A phase I study of ispinesib, a kinesin spindle protein inhibitor, administered weekly for three consecutive weeks of a 28-day cycle in patients with solid tumors

Suzanne F. Jones, H. Burris, S. Boerner, 2011, Investigational New Drugs.

Randomized phase I pharmacokinetic study of ipilimumab with or without one of two different chemotherapy regimens in patients with untreated advanced melanoma.

J. Wolchok, S. Chasalow, S. O’Day, 2013, Cancer immunity.

Population Pharmacokinetics of Eltrombopag in Healthy Subjects and Patients With Chronic Idiopathic Thrombocytopenic Purpura

D. Ouellet, Daphne D Williams, E. Gibiansky, 2011, Journal of clinical pharmacology.

Metabolic Chiral Inversion of Brivanib and Its Relevance to Safety and Pharmacology

Yuan-qing Xia, M. Jemal, J. Gan, 2012, Drug Metabolism and Disposition.

Effects of food and antacids on the pharmacokinetics of eltrombopag in healthy adult subjects: two single-dose, open-label, randomized-sequence, crossover studies.

B. Peng, Daphne D Williams, Yanli Deng, 2009, Clinical therapeutics.